National expansion of antiretroviral treatment in thailand, 2000-2007: Program scale-up and patient outcomes

Journal of Acquired Immune Deficiency Syndromes

Volumn 50, Issue 5, 2009, Pages 506-512

  Chasombat, Sanchai ^a   McConnell, Michelle S ^a,b   Siangphoe, Umaporn ^a   Yuktanont, Porntip ^a   Jirawattanapisal, Thidaporn ^a   Fox, Kimberley ^a,b   Thanprasertsuk, Sombat ^c   Mock, Philip A ^a   Ningsanond, Peeramon ^a   Lertpiriyasuwat, Cheewanan ^a   Pinyopornpanich, Somchai ^a  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Antiretroviral; HIV; National; Thailand; Treatment outcomes

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCALE UP; SURVIVAL RATE; SURVIVAL TIME; THAILAND; HEALTH CARE DELIVERY; MORTALITY; OUTCOME ASSESSMENT; PUBLIC HEALTH; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); THAILAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65449153994     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181967602     Document Type: Article

References (18)

1. World Health Organization. Scaling up antiretroviral therapy in resourcelimited settings: treatment guidelines for a public health approach. Available at: http://www.who.int/3by5/publications/documents/arv-guidelines/en/. Accessed April 20, 2007.
2. World Health Organization. The 3 by 5 initiative. Available at: http://www.who.int/3by5/en/. Accessed April 20, 2007.
3. Chasombat S, Lertpiriyasuwat C, Thanprasertsuk S, et al. The national access to antiretroviral program for PHA (NAPHA) in Thailand. Southeast Asian J Trop Med Public Health. 2006;37:704-715.
4. Phanuphak P. Antiretroviral treatment in resource-limited settings: what can we learn from the existing programmes in Thailand? AIDS. 2004;18: S33-S38.
5. Ford N, Wilson D, Costa Chavez G, et al. Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand. AIDS. 2007;21:S21-S29.
6. Stringer J, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia. JAMA. 2006;296:782-793.
7. El-Sadr W, Elul B, Hawken M, et al. Variability in populations enrolled and their outcomes in HIV care and treatment programs across countries in Sub-Saharan Africa. Paper presented at: 14th Conference on Retroviruses and Opportunistic Infections; February 19-23, 2007; Los Angeles, CA.
8. Van Cutsem G, Hilderbrand K, Coetzee D, et al. Clinical outcomes and emerging challenges after 5 years of ART in a South African township. Paper presented at: 14th Conference on Retroviruses and Opportunistic Infections; February 19-23, 2007; Los Angeles, CA.
9. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006;367:1335-1342.
10. Coetzee D, Hilderbrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18:887-895.
11. CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41:961-962.
12. Teixeira P, Vitoria M, Barcarolo J. Antiretroviral treatment in resourcepoor settings: the Brazilian experience. AIDS. 2004;18:S5-S7.
13. Kilsztajn S, Lopes E, Santos Nunes do Carmo M, et al. Improvement in survival among symptomatic AIDS patients by exposure category in Sao Paulo. J Acquir Immune Defic Syndr. 2007;45:342-347.
14. The Antiretroviral Therapy (ART) Cohort Collaboration. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet. 2006; 368:451-458.
15. ART-LINC. Mortality of HIV-1 infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.
16. Phillips A, Grabar S, Tassie J-M, et al. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. AIDS. 1999;13: 2075-2082.
17. Kuritzkes D. Extending antiretroviral therapy to resource-poor settings: implications for drug resistance. AIDS. 2004;18:S45-S48.
18. World Health Organization. Scaling up Antiretroviral Treatment: Lessons Learnt From Thailand. Report of an External Evaluation, 12-19 October 2004. World Health Organization Regional Office for South-East Asia, New Delhi, India. 2007.